[HTML][HTML] The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song, W Wu, D Zhu - Critical Care, 2018 - Springer
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
[HTML][HTML] The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song, W Wu… - Critical …, 2018 - ccforum.biomedcentral.com
Acute respiratory distress syndrome (ARDS) is a life-threatening condition with high mortality
that imposes a serious medical burden. Antiplatelet therapy is a potential strategy for …
that imposes a serious medical burden. Antiplatelet therapy is a potential strategy for …
The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song… - Critical care …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song, W Wu, D Zhu - Critical Care, 2018 - go.gale.com
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
an approximate 40% hospital mortality rate [1], costing 3.6 million hospital days annually in …
an approximate 40% hospital mortality rate [1], costing 3.6 million hospital days annually in …
[HTML][HTML] The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song, W Wu, D Zhu - Critical Care, 2018 - ncbi.nlm.nih.gov
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis.
Y Wang, M Zhong, Z Wang, J Song, W Wu… - Critical Care (London …, 2018 - europepmc.org
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis.
Y Wang, M Zhong, Z Wang, J Song, W Wu… - Critical Care (London …, 2018 - europepmc.org
Background Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
[PDF][PDF] The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
Y Wang, M Zhong, Z Wang, J Song, W Wu, D Zhu - 2018 - ccforum.biomedcentral.com
Background: Acute respiratory distress syndrome (ARDS) is a life-threatening condition with
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …
high mortality that imposes a serious medical burden. Antiplatelet therapy is a potential …